Edge of the world: Practical considerations and a clinical perspective of next-generation sequencing for hereditary cardiac disease

Brian C. Jensen, Monte S. Willis

Research output: Contribution to journalReview article

Abstract

In the article by Jongbloed et al. in the current issue of Expert Opinion on Medical Diagnostics entitled 'New clinical molecular diagnostic methods for congenital and inherited heart disease', the authors introduce the application of next-generation sequencing technologies to a wide range of genetically based cardiac diseases. Although these technologies certainly are exciting and hold great diagnostic promise, their impact is limited at present by insufficient correlation between genotype and phenotype in cardiac disease. In the following discussion, the application of genetic testing in the evaluation of two important familial cardiac diseases, familial cardiomyopathy and long QT syndrome, is considered.

Original languageEnglish (US)
Pages (from-to)5-8
Number of pages4
JournalExpert Opinion on Medical Diagnostics
Volume5
Issue number1
DOIs
StatePublished - Jan 1 2011

Fingerprint

Inborn Genetic Diseases
Heart Diseases
Technology
Long QT Syndrome
Molecular Pathology
Expert Testimony
Genetic Testing
Genetic Association Studies
Cardiomyopathies
Testing

Keywords

  • Arrhythmogenic right ventricular cardiomyopathy
  • Dilated cardiomyopathy
  • Familial cardiomyopathy
  • Genetic testing
  • Hypertrophic cardiomyopathy
  • Long QT syndrome
  • Review
  • Therapy

ASJC Scopus subject areas

  • Biomedical Engineering
  • Molecular Medicine
  • Biochemistry, medical

Cite this

@article{0dd3501467f1429f9832dabf2f98f786,
title = "Edge of the world: Practical considerations and a clinical perspective of next-generation sequencing for hereditary cardiac disease",
abstract = "In the article by Jongbloed et al. in the current issue of Expert Opinion on Medical Diagnostics entitled 'New clinical molecular diagnostic methods for congenital and inherited heart disease', the authors introduce the application of next-generation sequencing technologies to a wide range of genetically based cardiac diseases. Although these technologies certainly are exciting and hold great diagnostic promise, their impact is limited at present by insufficient correlation between genotype and phenotype in cardiac disease. In the following discussion, the application of genetic testing in the evaluation of two important familial cardiac diseases, familial cardiomyopathy and long QT syndrome, is considered.",
keywords = "Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Familial cardiomyopathy, Genetic testing, Hypertrophic cardiomyopathy, Long QT syndrome, Review, Therapy",
author = "Jensen, {Brian C.} and Willis, {Monte S.}",
year = "2011",
month = "1",
day = "1",
doi = "10.1517/17530059.2010.541239",
language = "English (US)",
volume = "5",
pages = "5--8",
journal = "Expert Opinion on Medical Diagnostics",
issn = "1753-0059",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Edge of the world

T2 - Practical considerations and a clinical perspective of next-generation sequencing for hereditary cardiac disease

AU - Jensen, Brian C.

AU - Willis, Monte S.

PY - 2011/1/1

Y1 - 2011/1/1

N2 - In the article by Jongbloed et al. in the current issue of Expert Opinion on Medical Diagnostics entitled 'New clinical molecular diagnostic methods for congenital and inherited heart disease', the authors introduce the application of next-generation sequencing technologies to a wide range of genetically based cardiac diseases. Although these technologies certainly are exciting and hold great diagnostic promise, their impact is limited at present by insufficient correlation between genotype and phenotype in cardiac disease. In the following discussion, the application of genetic testing in the evaluation of two important familial cardiac diseases, familial cardiomyopathy and long QT syndrome, is considered.

AB - In the article by Jongbloed et al. in the current issue of Expert Opinion on Medical Diagnostics entitled 'New clinical molecular diagnostic methods for congenital and inherited heart disease', the authors introduce the application of next-generation sequencing technologies to a wide range of genetically based cardiac diseases. Although these technologies certainly are exciting and hold great diagnostic promise, their impact is limited at present by insufficient correlation between genotype and phenotype in cardiac disease. In the following discussion, the application of genetic testing in the evaluation of two important familial cardiac diseases, familial cardiomyopathy and long QT syndrome, is considered.

KW - Arrhythmogenic right ventricular cardiomyopathy

KW - Dilated cardiomyopathy

KW - Familial cardiomyopathy

KW - Genetic testing

KW - Hypertrophic cardiomyopathy

KW - Long QT syndrome

KW - Review

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=78650582908&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650582908&partnerID=8YFLogxK

U2 - 10.1517/17530059.2010.541239

DO - 10.1517/17530059.2010.541239

M3 - Review article

C2 - 23484472

AN - SCOPUS:78650582908

VL - 5

SP - 5

EP - 8

JO - Expert Opinion on Medical Diagnostics

JF - Expert Opinion on Medical Diagnostics

SN - 1753-0059

IS - 1

ER -